Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS
Home/The Filing Wire/Aurora Cannabis Inc./ 6-K

SEC Filing · 6-K

Aurora Cannabis Inc.

SEC Filing

Filed Feb 18, 2026Accepted Feb 17, 2026, 7:12 PM ESTCIK 1683541Accession 0001279569-26-000136
View company →Permanent SEC source ↗
Share

Press release in this filing

Aurora to Participate in the TD Cowen 46th Annual Health Care Conference →

Company context

Aurora is a global leader in medical cannabis, dedicated to improving lives through scientific expertise, proven performance, and a deep commitment to patient care. Aurora serves medical markets across Canada, Europe, Australia, and New Zealand with a portfolio of trusted, leading brands including Aurora®, MedReleaf®, Pedanios®, IndiMed™, San Raf®, and Whistler Medical Marijuana Corporation®. With world-class GMP-certified manufacturing facilities in Canada and Germany, and a team of industry-leading professionals, Aurora continues to expand its global footprint and deliver consistent, high-quality cannabis products with the purpose of Opening the World to Cannabis™.

Current securities

ACBNASDAQ · EQUITY · CurrentACBTSX · EQUITY · Current
Historical securities (2)
ACBFFOTC · EQUITY · Historical · closed Oct 23, 2018ACBWFOTC · WARRANT · Historical · closed Apr 27, 2023

Recent company filings

  1. SC14D9F/A - filed by AURORA CANNABIS INC regarding AURORA CANNABIS INCOct 26, 2026
  2. 6-K filingOct 26, 2026
  3. SC14D9F/A - filed by AURORA CANNABIS INC regarding AURORA CANNABIS INCOct 15, 2026
  4. 6-K filingOct 14, 2026
  5. 6-K filingOct 8, 2026

As-filed source

Primary evidence
As filedOpen full document ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.